ArticlePharmacological reports : PR2020

Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway.

Nuriye Ezgi Bektur Aykanat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.